Optiver Holding
NVS icon

Optiver Holding’s Novartis NVS Stock Holding History

Optiver Holding’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.3M Sell
316,500
-351,000
-53% -$53.8M 0.02% 190
2025
Q4 		$92M Buy
667,500
+418,600
+168% +$54.8M 0.03% 123
2025
Q3 		$31.9M Buy
248,900
+5,400
+2% +$659K 0.01% 179
2025
Q2 		$29.5M Sell
243,500
-77,100
-24% -$8.69M 0.01% 122
2025
Q1 		$35.7M Sell
320,600
-142,000
-31% -$15.1M 0.02% 116
2024
Q4 		$45M Buy
462,600
+262,800
+132% +$28M 0.02% 108
2024
Q3 		$23M Sell
199,800
-83,100
-29% -$9.43M 0.01% 163
2024
Q2 		$30.1M Buy
282,900
+130,900
+86% +$13.1M 0.02% 181
2024
Q1 		$14.7M Sell
152,000
-82,500
-35% -$8.46M 0.01% 252
2023
Q4 		$23.7M Sell
234,500
-359,000
-60% -$34.7M 0.01% 215
2023
Q3 		$60.5M Sell
593,500
-207,400
-26% -$21.1M 0.04% 124
2023
Q2 		$80.8M Sell
800,900
-311,600
-28% -$31.2M 0.06% 111
2023
Q1 		$102M Sell
1,112,500
-265,000
-19% -$23.1M 0.07% 99
2022
Q4 		$125M Buy
1,377,500
+258,400
+23% +$21.8M 0.13% 69
2022
Q3 		$85.1M Buy
1,119,100
+148,800
+15% +$12.3M 0.07% 68
2022
Q2 		$82M Buy
970,300
+218,500
+29% +$19.2M 0.09% 63
2022
Q1 		$66M Sell
751,800
-1,072,200
-59% -$92.8M 0.06% 65
2021
Q4 		$156M Buy
1,824,000
+1,140,400
+167% +$94.7M 0.14% 50
2021
Q3 		$55.9M Buy
683,600
+101,400
+17% +$9.12M 0.05% 71
2021
Q2 		$53.1M Buy
+582,200
New +$51.8M 0.07% 57
2021
Q1 		– Hold
0
– – – 50

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Optiver Holding's NVS Position: Q1 2026 in Review

Optiver Holding reduced its Novartis (NVS) stake by 39% in Q1 2026, selling an estimated $9.04M and leaving 92,638 shares worth $14.2M. The position accounts for ﹤0.01% of the portfolio, ranked #318.

Optiver Holding first reported a position in NVS in Q1 2021 and has held it in 18 quarters since. The position peaked at $62.3M in Q2 2025. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Optiver Holding held 92,638 shares of Novartis worth $14.2M as of Q1 2026.
  • Optiver Holding sold 58,952 Novartis shares in Q1 2026, an estimated $9.04M.
  • Novartis made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #318 holding.
  • Optiver Holding first reported a position in Novartis in Q1 2021 and has held it in 18 quarters since.
  • Optiver Holding's Novartis position peaked at $62.3M in Q2 2025.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.